Rapid identification of bacteria isolated from blood cultures by direct matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) is now in widespread use in major centres but is not yet feasible in smaller hospital laboratories. A FilmArray multiplex PCR panel for blood culture isolate identification (BCID) provides an alternative approach to near point-of-care microbial identification in regional hospitals. We assessed the accuracy and time to identification of the BCID FilmArray in a consecutive series of 149 blood cultures from 143 patients in a teaching hospital and smaller regional hospitals, currently identified by direct MALDI-TOF and proprietary molecular methods. The BCID FilmArray contained 18 of 34 species and 20 of 23 species isolated from teaching and regional hospital, respectively. Overall, 85 % of the teaching hospital and 100 % of the regional hospital monomicrobial blood cultures were identified, compared with 60 and 68 %, respectively, for direct MALDI-TOF on the same cultures. There were no incorrect results from blood cultures containing Staphylococcus aureus, streptococci, Pseudomonas aeruginosa or Enterobacteriaceae. The three discrepant results were all in mixed cultures. The mean reduction in time to identification of blood culture isolates was 53 h, which did not include the time required to transport cultures from regional centres to a central laboratory. The overall performance of the BCID FilmArray is stronger in blood cultures from smaller regional hospitals that encounter a narrower range of bacterial species dominated by the commonest species. This approach is more suited to smaller clinical laboratories than the MALDI-TOF direct method.
INTRODUCTION
Sepsis is a potentially fatal, progressive disease in which prompt detection and identification of the infective agent can make a key contribution to time-critical clinical decisions. Without culture-based evidence for bloodstream infection, antimicrobial therapy cannot be effectively targeted, increasing the risk of treatment failure and emergence of antimicrobial resistance. Without effective antibiotic treatment, patients with sepsis deteriorate rapidly (Kumar et al., 2006) . Untreated sepsis results in an estimated 7.6 % decrease in survival with each hour's delay in effective therapy (Chaudhary et al., 2014) . Conventional blood culture methods require an interval of 24-48 h before laboratory methods identify the infective agent (Inglis et al., 2008) . Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) accelerates the isolate identification step for the majority of blood cultures in larger centres with a mass spectrometer (Martiny et al., 2013) , but smaller hospital laboratories do not benefit directly from MALDI-TOF identification. There have been many attempts to use molecular methods to speed up blood culture isolate identification (BCID), but their place in routine use remains uncertain (Dark et al., 2015) . The clinical impact of molecular detection of antimicrobial resistance in blood culture isolates is unclear, and may have less effect on antibiotic choice than predicted by laboratory-based studies (Huttunen et al., 2013) . One of the newer methods for BCID is a multiplex molecular method known as a FilmArray. The BCID FilmArray reduced time to identification of common bacterial species in North American and European centres (Altun et al., 2013; Southern et al., 2015) , but has not been tried in more sparsely populated regions where molecular diagnostic services and hospital services are often separated by large distances. The state of Western Australia experiences substantial delays in referred specimen processing because central laboratory services in the main metropolitan area are located hundreds of kilometres from regional hospitals. The aim of the current translational research project was to compare the performance of the BCID FilmArray in blood cultures from teaching and regional hospital patients.
METHODS
Laboratory setting. The study was conducted in the central complex of a pathology laboratory network that includes branch laboratories located throughout Western Australia. The central laboratory provides a clinical microbiology service to a wide range of acute medical specialties.
Blood culture procedure. The standard operating procedure relies on centralized processing of blood culture bottles from acute medical specialties on the teaching hospital campus in an automated analyser (Bactec FX; Becton Dickenson) and referred blood cultures from smaller regional hospitals with an automated blood culture analyser but limited culture identification capability. On weekday mornings, machine-positive blood cultures are processed at the start of the working day and identified by Gram staining and direct MALDI-TOF MS (Biotyper; Bruker Daltonic) to identify the wide range of bacterial species encountered in a teaching hospital setting. Rapid molecular methods are used selectively to identify meticillin and vancomycin resistance (GenXpert; Cepheid). Sporadic positive blood cultures signalled later in the day and difficult identifications such as mixed cultures are processed individually using conventional culturedependent identification procedures.
Reporting procedures. The laboratory provides a preliminary report on the blood culture Gram-stain result to the referring clinical service. This initial contact with the patient's medical team is made by a clinical microbiologist, who obtains information about the patient's admission diagnosis, critical co-morbidities, progress and presumptive antimicrobial therapy. These data are recorded in the laboratory information system (LIS). Early supplementary information from MALDI-TOF MS direct identification procedures and molecular resistance assays are then communicated to the referring clinical service as soon as they are available. Definitive bacterial identification and antimicrobial susceptibility test results are entered in the LIS and validated by a clinical microbiologist prior to the final laboratory report. Negative results are reported after 48 h incubation without evidence of bacterial growth.
Selection of blood culture for FilmArray. During the first phase of the study, we obtained consecutive blood cultures from the co-located teaching hospital between late morning and early evening, after the initial daily batch process had been completed and when machinepositive cultures were sporadic. This included cultures that appeared mixed on Gram staining. No out-of-hours positive cultures were processed. Duplicate cultures from single collection episodes were avoided, but the occasional repeat cultures from extended investigation of recurrent fever were not excluded. We commenced the second phase of the study on completion of the first phase at approximately 90 cultures. The second phase examined consecutive blood cultures from regional centres that arrived during office hours once these had been logged into the central laboratory blood culture process.
FilmArray. Once a blood culture had been selected for FilmArray, the multiplex PCR FilmArray (BCID, BioFire/bioMérieux) was inoculated according to manufacturer's instructions. In brief, the array pack was opened immediately before inoculation. The array was discarded on the rare occasions when the vacuum seal had already been breached. A 100 ml aliquot of blood culture fluid was obtained from an aerobic culture bottle in a 1.0 ml syringe, mixed with proprietary buffer and 300 ml blood culture fluid was inoculated into the FilmArray pouch. The pouch was loaded, sample identification data were entered and the BCID protocol was set to run. The operating system automatically recorded the date and time of processing and completed each run in an hour. Results were recorded before the bacterial identification, and antimicrobial susceptibility data were obtained from the LIS. Potential discrepancies between conventional identification of blood culture isolates and FilmArray results were investigated while the original culture bottles and primary cultures were available. FilmArray results were not used to determine or guide any clinical decisions in specific septicaemic patients.
LIS data analysis. On completion of the second phase of FilmArray analysis, the entire set of electronic laboratory reports was reviewed for the definitive identification of all isolated bacteria, their antimicrobial susceptibilities, the clinical indication for blood culture, presumptive antibiotics, patient transfer between hospitals, increased acuity of care, laboratory-guided change in antibiotics and other infectious disease management advice. The major time points in the laboratory specimen journey were identified from the LIS.
Discrepant analysis protocol. In all cases where FilmArray results differed from definitive conventional identifications, the blood culture bottles were retrieved and checked against the specimen handling number on the 100 ml FilmArray aliquot container to ensure they came from the correct bottle. Gram-stain results were checked to ensure they matched the species detected by FilmArray. The primary inoculation plates were checked and the MALDI-TOF MS results scrutinized. Where required, both bottles in the pair were subcultured onto fresh medium and the conventional identification process was repeated. In one case, this required setting up a substrate utilization (API 20E; bioMérieux) panel to resolve a discrepancy for which MALDI-TOF MS was unsuitable.
Statistical analysis. The outcome measures used were time to BCID by conventional laboratory methods, direct MALDI-TOF MS procedure and FilmArray multiplex PCR; the proportion of complete species-level and partial identifications to genus level by these methods, and the predicted impact of FilmArray on overall time to identification. We analysed our results with a statistical software package (Prism 6.0; GraphPad), using Fisher's exact test for contingency analysis, descriptive column statistics and life table analysis. The threshold for statistical significance was Pv0.05. Data, statistical methods and inferences were independently reviewed by a biostatistician.
RESULTS
A total of 149 blood cultures were analysed from 143 patients, comprising 89 consecutive machine-positive blood cultures from a teaching hospital (86 patients) and 60 from referring regional hospitals (57 patients). The expected clinical significance of monomicrobial isolates was determined by their identity in three categories in accordance with the laboratory's standard procedures.
These were isolates of probable clinical significance (e.g. Staphylococcus aureus, Streptococcus pneumoniae, Escherichia coli, P. aeruginosa), possible clinical significance (e.g. Staphylococcus epidermidis and other species whose significance is context dependent, such as central line-associated bacteraemia) and doubtful clinical significance (e.g. Propionibacterium acnes and other species most commonly assessed as probable skin contaminants). All of the 17 meticillinsusceptible Staphylococcus aureus (MSSA) and three meticillin-resistant Staphylococcus aureus (MRSA) isolates were correctly identified by the FilmArray. There were no falsepositive FilmArray results. There were three false negatives: all three were polymicrobial blood cultures, with one or more dominant isolate detected, and one missed isolate that was not evident on the Gram stain. The other bacteria that were not detected on FilmArray were all species that were not in the target panel: two Campylobacter spp. and one each of Bacteroides, Heliococcus and Micrococcus sp.
Profile of blood culture isolates
The teaching hospital blood cultures contained 34 different species of which 18 (53 %) were represented in the FilmArray. The regional hospital blood cultures, in contrast, contained 23 species of which 20 (87 %) were in the FilmArray (Fisher's exact test, P50.0099). Specimens from the teaching and regional hospitals contained different proportions of polymicrobial and monomicrobial infections (Table 1a) , as well as differences in the clinical significance of isolated species, as shown below (Table 1b ). These differences in the range of isolates affected the relative performance of the BCID FilmArray compared with direct MALDI-TOF MS analysis (Table 2) .
Analysis of BCID FilmArray performance
There was an 85 % identification rate for teaching hospital cultures and 100 % for regional hospital cultures using the FilmArray. In contrast, the direct MALDI-TOF MS method identification rate was 60 % for clinically relevant monomicrobial isolates for teaching hospital cultures and 68 % for regional hospital cultures (Table 3 ). The FilmArray produced more identifications for teaching hospital blood culture isolates than direct MALDI-TOF MS (Fisher's exact test, P50.0077) and for significant isolates from regional hospital blood cultures (Fisher's exact test, P50.0027). As shown in Fig. 1 , application of the BCID FilmArray in both regional and teaching hospital settings resulted in significantly reduced time to bacterial identification when compared with conventional diagnostic procedures. Use of the BCID FilmArray had a significant beneficial effect on cumulative identification times in both teaching and regional hospital blood cultures (Fig. 2) . The reduction in mean time to identification was from 94 to 41 h for significant monomicrobial cultures from the teaching hospital identified by BCID FilmArray and from 88 to 36 h for regional hospital blood cultures (a decrease of 53 and 52 h, respectively). These intervals were significantly different (Pv0.0001).
Application of the BCID FilmArray result to clinical service
During the initial teaching hospital series, all blood culture results from intensive care patients and 20/25 (80 %) emergency department blood culture isolates were correctly identified by the FilmArray. In addition, the FilmArray identified isolates from 25/26 (96 %) patients needing an immediate change of antibiotic therapy and from 10/11 DDirect MALDI-TOF MS was used for one-off machine-positive blood culture identification on a discretionary basis. Where the clinical laboratory did not analyse positive bottles by the direct method, the actual number of sets tested is given as the denominator value. (91 %) patients requiring onward hospital transfer. Nine of these 10 (90 %) were from regional hospitals. Isolates from 9/10 (90 %) patients needing immediate infectious diseases consultation and from 3/4 (75 %) patients needing recall to hospital because of a positive blood culture were identified by the FilmArray.
DISCUSSION
Accuracy of the BCID FilmArray BCID processes have undergone fundamental changes since our previous study a decade ago (Inglis et al., 2008) . Provision of timely BCID results for Australian teaching hospital patients remains a high priority for clinical microbiology services, but it is clear from European data that the large distances between centralized laboratory services and smaller regional hospitals delay BCID (Schmitz et al., 2013) . In a recent comparison of the BCID FilmArray with a rapid mass spectrometer BCID method, the FilmArray was comparable with spectrometry for the more common bacteria encountered in blood cultures but covered a much smaller breadth of species (Rand & Delano, 2014) . As that study did not address the blood culture services operated by much smaller hospitals, we needed to establish whether the reduced breadth of species coverage in the BCID FilmArray would lead to a lower identification rate in regional laboratories.
Our results indicate that the opposite is the case. The BCID FilmArray identified 100 % of clinically significant isolates from our series of blood cultures from Western Australian regional hospitals. The higher identification rate compared with that in teaching hospital cultures reflects the greater pathogen diversity among blood culture isolates from the teaching hospital culture series as a consequence of the range of specialist services and complex patients concentrated there.
Comparison of the BCID FilmArray with MALDI-TOF
The significantly better performance of the BCID FilmArray over the direct MALDI-TOF MS BCID method in both teaching and regional hospital settings was a surprise in view of the favourable performance in a recent metaanalysis of the MALDI-TOF MS method used in this study (Morgenthaler & Kostrzewa, 2015) . MALDI-TOF MS produced more no-reliable-identification (NRI) results, which included Streptococcus pneumoniae, Streptococcus agalactiae, Staphylococcus aureus and Gramnegative isolates. An NRI result for Staphylococcus aureus is particularly serious because a failure in prompt recognition of Staphylococcus aureus delays the use of rapid molecular confirmation of MRSA. By contrast, the 100 % sensitivity and specificity of the BCID FilmArray for MSSA and MRSA in this series reassured us that an early opportunity to detect these important bacterial isolates would not be missed. MALDI-TOF MS failed completely in direct identification of Streptococcus pneumoniae and Streptococcus agalactiae and is well known to have difficulties with invasive streptococci (Martinez Teaching 3 (43) 3 (43) 1 (14) 7 (100) Regional 5 (56) 4 (44) 0 9 (100) Total 8 (50) 7 (44) 1 (6) 16 (100) *All elements of polymicrobial culture were identified to at least genus level.
DCorrect identification of at least one but not all isolates in polymicrobial blood culture. et al., 2014), whereas the BCID FilmArray identified both of these species in all cases. Indeed, there were no BCID FilmArray errors in identification of significant species from monobacterial blood cultures.
Time to identification (h)
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Discrepant BCID results
We investigated a total of five possible discrepant results and ruled out two of these: one as a MALDI-TOF MS error (Escherichia albertii called E. coli) (Inglis et al., 2015) and the other as a blood culture set that contained different species in each bottle. In the last instance, repeat subculture of the original bottles confirmed the FilmArray result (E. coli) from the single bottle tested. The three remaining discrepant results all contained two species, only one of which was visible in the initial Gram stain. In all three remaining discrepant results, the BCID FilmArray correctly identified the dominant species and missed the minority species that were not visible on Gram stain. These partially discrepant results may reflect a difference in the bacterial DNA template load, as the FilmArray was used to analyse a mixed bacterial population in these three cases. With these exceptions, the BCID FilmArray was able to identify mixed cultures of up to three species simultaneously, consistent with previous reports (Altun et al., 2013; Southern et al., 2015) . 
CONCLUSION
In light of our experience, this BCID rapid method appears suited to our regional hospital laboratory network in which it offers a mean saving of over 52 h to isolate identification and delivers a result in 27 % more cultures than a direct MALDI-TOF MS method. The role of the FilmArray in a large teaching hospital is a little less clear, as this will depend on the range of specialist and acute general medical services available. In our location, a teaching hospital role for the BCID FilmArray appears to be near-point-of-care testing of emergency department and intensive care blood cultures, plus failed MALDI-TOF MS direct culture identifications including those that appear mixed on the Gram stain. There is now a need to assess the clinical and health economic impact of the BCID FilmArray in more distant regional hospital centres where the potential benefit of reducing long-distance inter-hospital transfer makes a case for near-point-of-care clinical laboratory tests for blood culture identification.
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